Adapting analytics and quality control in cell therapy manufacturing to ensure adequate safety, purity, and potency of final products
25 Feb 2025
C & G Manufacturing
- How can manufacturers develop an effective potency assurance strategy to guarantee the consistency and efficacy of cell therapy products?
- What essential steps should be taken for comprehensive drug product characterization to evaluate the safety, purity, and potency of cell and gene therapy (CGT) products?
- Why is it crucial to establish a clear connection between critical process parameters (CPPs) and critical quality attributes (CQAs) when developing a robust manufacturing process?
Industry Expert
